Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.

Ora Israel(Technion – Israel Institute of Technology), Diana Gaitini(Technion – Israel Institute of Technology), Nissim Haim(Technion – Israel Institute of Technology), Eldad J. Dann(Rambam Health Care Campus), Michal Mekel, Myriam Ben-Arush, Alex Frenkel(Girls Incorporated), Ron Epelbaum(University of Bern), Nirit Hermony, Rachel Bar‐Shalom(Rambam Health Care Campus)
PubMed
October 1, 2002
Cited by 34

Related Papers

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
|Human Reproduction|1996|266